Human Reproduction, Vol. 18, No. 8, 1570-1573,
August 2003
© 2003 European Society of Human Reproduction and Embryology
Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk
Department of Obstetrics and Gynecology, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, USA
1 To whom correspondence should be addressed. e-mail: hugh.taylor{at}yale.edu
BACKGROUND: Cardiovascular disease is the leading cause of death in women, with most deaths occurring after menopause. It had been assumed that lack of estrogen is a leading contributing factor to cardiovascular disease in women. Recent trials, however, using hormone replacement therapy to treat cardiovascular disease in women have not affirmed the cardiovascular benefits ascribed to this regimen. Ovarian function declines slowly over the decades approaching the menopause as evidenced by declining fertility, rising serum FSH, falling inhibin, yet normal estradiol levels. We investigated the relationship between basal FSH and an established major risk factor for cardiovascular disease. METHODS AND RESULTS: We obtained cycle day 3 serum FSH levels and fasting lipoprotein profiles on 40 women between the ages of 29 and 49 years, with normal menstrual cycles and who were not using hormonal medications or statins. Premenopausal women with an FSH level
7 IU/l had significantly elevated total cholesterol (P = 0.009) and LDL (P = 0.019) compared with those with FSH <7 IU/l. This difference was independent of age. Neither HDL nor triglyceride levels differed between the two groups. CONCLUSIONS: Decreased functional ovarian reserve, as approximated by serum day 3 FSH levels, correlates with known cardiovascular risk factors. Declining ovarian function prior to estrogen deficiency may be a cardiac risk factor. The premenopausal ovary may be a source of cardioprotective substance other than estradiol. We hypothesize that factors other than 17
-estradiol, but related to ovarian function, might contribute to cardiovascular risk.
Key words: cardiovascular disease/cholesterol/FSH/lipids/ovary
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G.H. Woldringh, M.H.A. Frunt, J.A.M. Kremer, and M.E.A. Spaanderman Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies Hum. Reprod., November 1, 2006; 21(11): 2948 - 2954. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bondy and V. K. Bakalov Genetic vs Hormonal Factors in Lipid Metabolism in Women--Reply JAMA, January 28, 2004; 291(4): 425 - 425. [Full Text] [PDF] |
||||
![]() |
H. S. Taylor Genetic vs Hormonal Factors in Lipid Metabolism in Women JAMA, January 28, 2004; 291(4): 424 - 425. [Full Text] [PDF] |
||||

